Napabucasin Provides No Added Benefit in Metastatic Pancreatic Cancer
The phase 3 CanStem111P study was terminated early due to futility.
Pancreatic Cancer
Oral Wnt Pathway Inhibitor Gets Orphan Drug Status for Pancreatic Cancer
Currently, SM08502 is being evaluated in a Phase 1, open-label, multicenter, dose escalation study (NCT03355066) in 42 adult patients with advanced solid tumors for whom standard therapy is not available for their stage of diagnosis.
First-in-Class Pancreatic Cancer Candidate Gets Fast Track Status
Pamrevlumab is a first-in-class antibody developed by FibroGen to inhibit the activity of connective tissue growth factor.
New App May Help Screen for Pancreatic Cancer via Selfie
The ‘BiliScreen’ app uses a smartphone camera; by taking a picture of the user’s eyes it can calculate the color formation of the sclera and correlates it to the correct bilirubin level
Pancreatic Enzyme Replacement Beneficial for Pancreatic Cancer Patients
Data on nutritional markers (body mass index [BMI], albumin, total cholesterol) were collected at baseline and then assessed at 16 weeks; change from baseline was compared between the two groups.
Novel Pancreatic Cancer Treatment Granted Orphan Drug Status
Ability Pharmaceuticals has announced that the Food and Drug Administration has granted orphan drug designation to ABTL0812, an investigational candidate for pancreatic cancer.
Insulin-Related CA Risks May Be Offset by Statin Use
For patients with type 2 diabetes mellitus (T2DM), use of statins offsets insulin-related cancer risks, according to research published online in the Journal of Internal Medicine.
Recent Pancreatic Cancer Findings May Open Door for Novel Treatments
Scientists who discovered that pancreatic cancer is at least four separate diseases say their findings could lead to improved treatments for the disease.
Concerns Over Incretin-Based Drugs, Pancreatic Cancer Risk Addressed in New Study
A new international, multicenter study has found that incretin-based drugs, used to treat type 2 diabetes, are not associated with an increased risk of pancreatic cancer.
Can Metformin be Beneficial in Slowing Pancreatic Cancer?
Metformin may inhibit the progression of pancreatic cancer by decreasing inflammation and fibrosis, a study published in PLOS One reported.
